Brandon Shiau, MD
Internal Medicine · Manhattan Beach
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 9 years
- University of California, San Diego School of Medicine, 2017
Offices
2 locations · The Regents of the University of California · 1,426 clinicians in this group
Hospitals listed: Ronald Reagan UCLA Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Shiau’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ronald Reagan UCLA Medical CenterLos Angeles, CAAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of Jonsson Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 6.27 (4.69 to 7.85) · 3,570 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 5.17 (1.78 to 8.56) · 1,778 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.21 (0 to 0.62) · 8,165 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.59, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.611, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.503, Oct 2024 – Sep 2025
See every measure and the patient survey for Ronald Reagan UCLA Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 6.27 (4.69 to 7.85) · 3,570 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.17 (1.78 to 8.56) · 1,778 cases | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.62) · 8,165 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.59 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.611 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.503 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.67 (0 to 1.44) · 2,883 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.7 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.14 (139.88 to 202.41) · 282 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 122 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.5 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.9 · 350 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.1 · 436 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.8 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.4 · 3,004 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 9,102 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.09 to 0.44) · 10,460 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.67 (0.57 to 2.77) · 1,972 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.27 to 3.44) · 3,000 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.93 (3.76 to 8.09) · 2,101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.65 (1.31 to 3.98) · 1,032 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.56 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.626 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 138 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 357 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -7.1 · 122 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12.9 · 385 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 13.6 · 427 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 404 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.7 to 6.5) · 609 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.3 (10.1 to 15) · 609 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.8 · 119 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.5 to 13.7) · 2,701 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,463 cases | No different | Jan 2024 – Dec 2024 |
What patients said (814 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$12,408
Medicare paid this office $12,408 for 97 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $2,408 | $100 |
| Short return visit (20+ min) | 35 | $2,170 | $57 |
| Return visit (30+ min) | 32 | $2,116 | $66 |
Who their Medicare patients are
97 Original Medicare patients in 2024. Average age 73 · Women 41% · Also on Medicaid 12% · Health risk score 0.87. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 53% · Diabetes 20% · Atrial fibrillation 11% · Depression 11%.
The office billed $98,390, Medicare allowed $16,444 and paid $12,408; for 188 services of 27 kinds; $2,399 of it was for drugs given in the office and $10,009 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 97 | 188 | 73 | 0.87 | $98,390 | $12,408 |
| 2023 | 17 | 25 | 68 | 0.70 | $6,167 | $2,052 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$19,786 in 2024
Medicaid paid $19,786 for 116 billed services this clinician did in 2024, up to 33 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 81 | $15,025 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 65 years and older | 13 | $4,030 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 22 | $731 |
| 2024 | 116 | 3 | 33 | $19,786 |
| 2023 | 471 | 4 | 44 | $66,330 |
| 2022 | 423 | 5 | 36 | $57,302 |
| 2021 | 61 | 1 | 22 | $11,320 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 382 | $62,764 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 15 | $1,556 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 56 | $1,290 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 18 | $720 |
2022
| Return visit (30+ min) | 291 | $53,441 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 78 | $1,920 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 14 | $1,215 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 14 | $700 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 26 | $26 |
2021
| Return visit (30+ min) | 61 | $11,320 |
Drugs they prescribed that Part D paid
$275,271
Pharmacies billed $275,271 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (29 of 5,656) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
5,072 generic and 451 brand-name prescriptions · $275,271 in drug cost · 37 antibiotic prescriptions to 26 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 20 | $34,078 | $1,704 |
| Jardiance | 52 | $28,048 | $539 |
| Pradaxa | 78 | $19,552 | $251 |
| Humulin 70/30 Kwikpen | 33 | $10,757 | $326 |
| Wixela Inhub | 43 | $8,736 | $203 |
See all 74 drugs
| Eliquis | 20 | $34,078 | $1,704 |
| Jardiance | 52 | $28,048 | $539 |
| Pradaxa | 78 | $19,552 | $251 |
| Humulin 70/30 Kwikpen | 33 | $10,757 | $326 |
| Wixela Inhub | 43 | $8,736 | $203 |
| Humulin N | 47 | $8,528 | $181 |
| Atorvastatin | 605 | $7,507 | $12 |
| Spiriva Respimat | 15 | $5,394 | $360 |
| Losartan | 389 | $5,061 | $13 |
| Terazosin | 90 | $4,708 | $52 |
| Levothyroxine | 201 | $3,792 | $19 |
| Humulin N Kwikpen | 24 | $3,542 | $148 |
| Amlodipine Besylate | 284 | $3,524 | $12 |
| Alvesco | 18 | $2,969 | $165 |
| Glipizide-Metformin | 29 | $2,917 | $101 |
| Lisinopril | 245 | $2,908 | $12 |
| Metformin | 236 | $2,811 | $12 |
| Rosuvastatin | 184 | $2,099 | $11 |
| Tamsulosin | 103 | $1,952 | $19 |
| Potassium Chloride | 48 | $1,828 | $38 |
| Hydrochlorothiazide | 153 | $1,738 | $11 |
| Gabapentin | 79 | $1,654 | $21 |
| Humulin R | 14 | $1,653 | $118 |
| Glipizide | 140 | $1,645 | $12 |
| Nano 2nd Gen Pen Needle | 63 | $1,584 | $25 |
| Simvastatin | 118 | $1,396 | $12 |
| Bisoprolol | 54 | $1,392 | $26 |
| Atenolol | 110 | $1,379 | $13 |
| Omeprazole | 107 | $1,179 | $11 |
| Metoprolol | 101 | $1,112 | $11 |
| Alendronate | 108 | $1,045 | $10 |
| Clopidogrel | 55 | $1,030 | $19 |
| Albuterol Sulfate Hfa | 51 | $987 | $19 |
| Metformin Hcl Er | 100 | $927 | $9 |
| Furosemide | 78 | $925 | $12 |
| Lisinopril-Hydrochlorothiazide | 73 | $874 | $12 |
| Estradiol | 17 | $791 | $47 |
| Allopurinol | 52 | $712 | $14 |
| Trazodone | 48 | $607 | $13 |
| Losartan-Hydrochlorothiazide | 46 | $587 | $13 |
| Azelastine | 29 | $585 | $20 |
| Finasteride | 37 | $576 | $16 |
| Veo Insulin | 29 | $573 | $20 |
| Fluticasone Propionate | 37 | $565 | $15 |
| Adacel Tdap | 11 | $561 | $51 |
| Benazepril | 27 | $552 | $20 |
| Pantoprazole | 45 | $510 | $11 |
| Carvedilol | 46 | $505 | $11 |
| Diltiazem 24hr Er (Cd) | 17 | $476 | $28 |
| Famotidine | 33 | $426 | $13 |
| Hydrocodone-Acetaminophen | 19 | $392 | $21 |
| Spironolactone | 34 | $369 | $11 |
| Metoprolol | 33 | $367 | $11 |
| Nifedipine Er | 11 | $345 | $31 |
| Pravastatin | 29 | $329 | $11 |
| Lovastatin | 26 | $327 | $13 |
| Mirtazapine | 22 | $321 | $15 |
| Ciclopirox | 18 | $311 | $17 |
| Triamcinolone Acetonide | 18 | $302 | $17 |
| Chlorhexidine Gluconate | 14 | $298 | $21 |
| Sertraline | 20 | $255 | $13 |
| Fenofibrate | 12 | $255 | $21 |
| Meloxicam | 38 | $251 | $7 |
| Fluoxetine | 19 | $223 | $12 |
| Hydralazine | 17 | $210 | $12 |
| Hydrocortisone | 15 | $209 | $14 |
| Veo Insulin | 12 | $194 | $16 |
| Ibuprofen | 18 | $189 | $10 |
| Montelukast | 14 | $159 | $11 |
| Pioglitazone | 12 | $137 | $11 |
| Triamterene-Hydrochlorothiazid | 14 | $135 | $10 |
| Citalopram Hbr | 11 | $128 | $12 |
| Chlorthalidone | 11 | $126 | $11 |
| Clonidine | 11 | $104 | $9 |
Year by year
| 2024 | 5,656 | 949 | 1% (29) | 8% | $275,271 |
| 2023 | 9,217 | 1,211 | 1% (126) | 10% | $458,045 |
| 2022 | 7,429 | 1,339 | 3% (189) | 11% | $422,140 |
| 2021 | 503 | 242 | 4% (19) | None | $44,965 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 111 drugs
| Eliquis | 39 | $54,621 | $1,401 |
| Jardiance | 75 | $52,717 | $703 |
| Pradaxa | 123 | $31,650 | $257 |
| Victoza 2-Pak | 14 | $20,448 | $1,461 |
| Humulin 70/30 Kwikpen | 51 | $17,683 | $347 |
| Atorvastatin | 773 | $12,054 | $16 |
| Humulin N | 71 | $11,282 | $159 |
| Entresto | 11 | $11,072 | $1,007 |
| Spiriva Respimat | 30 | $9,219 | $307 |
| Wixela Inhub | 47 | $8,855 | $188 |
| Terazosin | 132 | $7,338 | $56 |
| Losartan | 565 | $7,291 | $13 |
| Humulin N Kwikpen | 50 | $6,883 | $138 |
| Levothyroxine | 269 | $6,183 | $23 |
| Amlodipine Besylate | 423 | $5,417 | $13 |
| Alvesco | 34 | $5,394 | $159 |
| Spiriva Handihaler | 11 | $5,107 | $464 |
| Symbicort | 13 | $4,828 | $371 |
| Lisinopril | 384 | $4,617 | $12 |
| Metformin | 360 | $4,448 | $12 |
| Humulin 70-30 | 33 | $4,252 | $129 |
| Rosuvastatin | 293 | $3,911 | $13 |
| Glipizide-Metformin | 39 | $3,410 | $87 |
| Omeprazole | 289 | $3,337 | $12 |
| Gabapentin | 154 | $3,162 | $21 |
| Tamsulosin | 160 | $3,093 | $19 |
| Humulin R | 24 | $2,913 | $121 |
| Glipizide | 221 | $2,826 | $13 |
| Potassium Chloride | 77 | $2,747 | $36 |
| Bisoprolol | 92 | $2,564 | $28 |
| Hydrochlorothiazide | 214 | $2,472 | $12 |
| Albuterol Sulfate Hfa | 117 | $2,074 | $18 |
| Nano 2nd Gen Pen Needle | 87 | $1,955 | $22 |
| Atenolol | 159 | $1,942 | $12 |
| Metoprolol | 170 | $1,940 | $11 |
| Alendronate | 171 | $1,926 | $11 |
| Simvastatin | 162 | $1,886 | $12 |
| Eplerenone | 13 | $1,712 | $132 |
| Furosemide | 124 | $1,560 | $13 |
| Metformin Hcl Er | 153 | $1,504 | $10 |
| Lisinopril-Hydrochlorothiazide | 109 | $1,359 | $12 |
| Diclofenac | 30 | $1,312 | $44 |
| Hydrocodone-Acetaminophen | 80 | $1,274 | $16 |
| Clopidogrel | 63 | $1,203 | $19 |
| Estradiol | 26 | $1,198 | $46 |
| Famotidine | 78 | $1,189 | $15 |
| Pantoprazole | 98 | $1,149 | $12 |
| Fluticasone Propionate | 76 | $1,062 | $14 |
| Finasteride | 67 | $974 | $15 |
| Pravastatin | 41 | $964 | $24 |
| Diltiazem 24hr Er (Cd) | 27 | $898 | $33 |
| Metoprolol | 33 | $897 | $27 |
| Veo Insulin | 37 | $887 | $24 |
| Azelastine | 50 | $844 | $17 |
| Trazodone | 74 | $839 | $11 |
| Meloxicam | 114 | $788 | $7 |
| Colchicine | 33 | $782 | $24 |
| Triamcinolone Acetonide | 55 | $782 | $14 |
| Allopurinol | 55 | $733 | $13 |
| Carvedilol | 65 | $732 | $11 |
| Gavilyte-C | 34 | $714 | $21 |
| Ciclopirox | 34 | $714 | $21 |
| Mirtazapine | 45 | $711 | $16 |
| Propranolol | 18 | $684 | $38 |
| Benazepril | 31 | $654 | $21 |
| Losartan-Hydrochlorothiazide | 55 | $624 | $11 |
| Hydralazine | 27 | $606 | $22 |
| Nifedipine Er | 14 | $600 | $43 |
| Lactulose | 23 | $562 | $24 |
| Spironolactone | 46 | $557 | $12 |
| Trospium Chloride | 11 | $476 | $43 |
| Sertraline | 36 | $468 | $13 |
| Duloxetine | 19 | $465 | $24 |
| Lovastatin | 37 | $448 | $12 |
| Pioglitazone | 24 | $442 | $18 |
| Betamethasone Diprop Augmented | 14 | $428 | $31 |
| Temazepam | 29 | $417 | $14 |
| Veo Insulin | 22 | $409 | $19 |
| Ibuprofen | 36 | $407 | $11 |
| Fluoxetine | 29 | $394 | $14 |
| Veo Insulin | 18 | $389 | $22 |
| Nitroglycerin | 14 | $388 | $28 |
| Hydrocortisone | 30 | $385 | $13 |
| Acyclovir | 21 | $380 | $18 |
| Tramadol | 37 | $376 | $10 |
| Citalopram Hbr | 30 | $347 | $12 |
| Naproxen | 21 | $332 | $16 |
| Chlorthalidone | 27 | $330 | $12 |
| Nabumetone | 12 | $313 | $26 |
| Fenofibrate | 13 | $311 | $24 |
| Bupropion Xl | 15 | $303 | $20 |
| Donepezil | 20 | $298 | $15 |
| Nystatin | 16 | $280 | $17 |
| Clonidine | 16 | $266 | $17 |
| Glipizide Er | 11 | $265 | $24 |
| Montelukast | 22 | $247 | $11 |
| Memantine | 16 | $247 | $15 |
| Lorazepam | 33 | $243 | $7 |
| Paroxetine | 15 | $236 | $16 |
| Triamterene-Hydrochlorothiazid | 27 | $231 | $9 |
| Ketoconazole | 11 | $217 | $20 |
| Ezetimibe | 16 | $182 | $11 |
| Venlafaxine | 11 | $172 | $16 |
| Isosorbide Mononitrate Er | 12 | $160 | $13 |
| Ondansetron Odt | 17 | $156 | $9 |
| Sumatriptan | 15 | $145 | $10 |
| Buspirone | 16 | $142 | $9 |
| Chlorhexidine Gluconate | 11 | $136 | $12 |
| Clonazepam | 13 | $127 | $10 |
| Lansoprazole | 13 | $119 | $9 |
| Alprazolam | 15 | $106 | $7 |
2022: 107 drugs
| Pradaxa | 91 | $38,971 | $428 |
| Eliquis | 23 | $33,438 | $1,454 |
| Jardiance | 28 | $20,619 | $736 |
| Humulin 70/30 Kwikpen | 48 | $14,691 | $306 |
| Tradjenta | 13 | $9,581 | $737 |
| Wixela Inhub | 40 | $7,592 | $190 |
| Atorvastatin | 514 | $7,375 | $14 |
| Humulin 70-30 | 45 | $7,213 | $160 |
| Humulin N | 49 | $7,035 | $144 |
| Alvesco | 43 | $6,359 | $148 |
| Levothyroxine | 235 | $5,817 | $25 |
| Terazosin | 105 | $5,230 | $50 |
| Losartan | 410 | $5,220 | $13 |
| Symbicort | 13 | $4,833 | $372 |
| Spiriva Respimat | 13 | $4,621 | $355 |
| Amlodipine Besylate | 357 | $4,402 | $12 |
| Lantus | 19 | $4,048 | $213 |
| Humulin N Kwikpen | 28 | $3,830 | $137 |
| Lisinopril | 307 | $3,747 | $12 |
| Metformin | 302 | $3,662 | $12 |
| Humulin R | 26 | $3,063 | $118 |
| Rosuvastatin | 216 | $2,780 | $13 |
| Diclofenac | 78 | $2,763 | $35 |
| Omeprazole | 222 | $2,557 | $12 |
| Potassium Chloride | 67 | $2,543 | $38 |
| Glipizide | 168 | $2,248 | $13 |
| Gabapentin | 114 | $2,186 | $19 |
| Tamsulosin | 111 | $2,153 | $19 |
| Hydrocodone-Acetaminophen | 126 | $2,089 | $17 |
| Albuterol Sulfate Hfa | 111 | $1,970 | $18 |
| Adacel Tdap | 38 | $1,938 | $51 |
| Glipizide-Metformin | 27 | $1,910 | $71 |
| Hydrochlorothiazide | 167 | $1,903 | $11 |
| Metoprolol | 134 | $1,458 | $11 |
| Bisoprolol | 36 | $1,453 | $40 |
| Atenolol | 113 | $1,433 | $13 |
| Pantoprazole | 95 | $1,325 | $14 |
| Simvastatin | 114 | $1,260 | $11 |
| Alendronate | 120 | $1,249 | $10 |
| Fluoxetine | 23 | $1,242 | $54 |
| Fluocinonide | 11 | $1,079 | $98 |
| Famotidine | 82 | $1,065 | $13 |
| Triamcinolone Acetonide | 86 | $1,035 | $12 |
| Clopidogrel | 51 | $1,019 | $20 |
| Clorazepate Dipotassium | 11 | $1,014 | $92 |
| Furosemide | 84 | $994 | $12 |
| Mirtazapine | 49 | $994 | $20 |
| Losartan-Hydrochlorothiazide | 39 | $981 | $25 |
| Azelastine | 55 | $978 | $18 |
| Nano 2nd Gen Pen Needle | 42 | $870 | $21 |
| Lisinopril-Hydrochlorothiazide | 73 | $865 | $12 |
| Estradiol | 19 | $859 | $45 |
| Duloxetine | 39 | $816 | $21 |
| Finasteride | 55 | $799 | $15 |
| Colchicine | 35 | $790 | $23 |
| Pravastatin | 29 | $779 | $27 |
| Allopurinol | 49 | $754 | $15 |
| Trazodone | 64 | $753 | $12 |
| Veo Insulin | 29 | $741 | $26 |
| Metformin Hcl Er | 79 | $729 | $9 |
| Fluticasone Propionate | 50 | $659 | $13 |
| Hydralazine | 21 | $623 | $30 |
| Diltiazem 24hr Er (Cd) | 17 | $620 | $36 |
| Klor-Con 8 | 13 | $619 | $48 |
| Benazepril | 24 | $616 | $26 |
| Dicyclomine | 14 | $578 | $41 |
| Propranolol | 16 | $557 | $35 |
| Meloxicam | 74 | $511 | $7 |
| Carvedilol | 46 | $510 | $11 |
| Ciclopirox | 28 | $508 | $18 |
| Tramadol | 41 | $482 | $12 |
| Pioglitazone | 24 | $471 | $20 |
| Gavilyte-C | 26 | $460 | $18 |
| Sertraline | 32 | $458 | $14 |
| Betamethasone Diprop Augmented | 13 | $418 | $32 |
| Acetaminophen-Codeine | 21 | $409 | $19 |
| Digoxin | 15 | $408 | $27 |
| Amiodarone | 12 | $405 | $34 |
| Escitalopram | 19 | $390 | $21 |
| Veo Insulin | 20 | $372 | $19 |
| Veo Insulin | 17 | $363 | $21 |
| Lorazepam | 45 | $360 | $8 |
| Chlorthalidone | 28 | $341 | $12 |
| Temazepam | 31 | $335 | $11 |
| Bupropion Xl | 20 | $319 | $16 |
| Spironolactone | 26 | $310 | $12 |
| Ibuprofen | 29 | $308 | $11 |
| Naproxen | 20 | $299 | $15 |
| Proctozone-Hc | 18 | $287 | $16 |
| Citalopram Hbr | 24 | $285 | $12 |
| Nitroglycerin | 12 | $281 | $23 |
| Metoprolol | 18 | $280 | $16 |
| Ezetimibe | 12 | $275 | $23 |
| Lovastatin | 22 | $263 | $12 |
| Memantine | 11 | $228 | $21 |
| Montelukast | 20 | $225 | $11 |
| Nystatin | 11 | $220 | $20 |
| Triamterene-Hydrochlorothiazid | 24 | $201 | $8 |
| Hydrocortisone | 16 | $179 | $11 |
| Bupropion Hcl Sr | 12 | $179 | $15 |
| Alprazolam | 22 | $178 | $8 |
| Nitrofurantoin Mono-Macro | 12 | $167 | $14 |
| Tizanidine | 14 | $163 | $12 |
| Glimepiride | 11 | $148 | $13 |
| Warfarin | 12 | $139 | $12 |
| Ondansetron Odt | 12 | $119 | $10 |
| Clonazepam | 11 | $111 | $10 |
2021: 12 drugs
| Diclofenac | 30 | $880 | $29 |
| Adacel Tdap | 16 | $800 | $50 |
| Levothyroxine | 15 | $402 | $27 |
| Lisinopril | 24 | $293 | $12 |
| Losartan | 21 | $277 | $13 |
| Amlodipine Besylate | 23 | $274 | $12 |
| Gabapentin | 11 | $270 | $25 |
| Atorvastatin | 21 | $256 | $12 |
| Hydrocodone-Acetaminophen | 14 | $247 | $18 |
| Rosuvastatin | 19 | $218 | $11 |
| Metformin | 13 | $150 | $12 |
| Omeprazole | 12 | $110 | $9 |
Professional record
- NPI
- 1427588995
- Trained
- University of California, San Diego School of Medicine, 2017 · 9 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 5767 W Century Blvd Ste 400, Los Angeles, CA, 90045
- NPI first listed
- 2017-06-15
- NPI last updated
- 2024-07-02
- NPI record certified
- 2024-07-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 751 S Bascom Ave, San Jose, CA, 95128
This office lists an electronic records connection.